Over the latest years, the incidence of West-Nile virus (WNV) infection has increased
dramatically in some Italian regions, as in the North-east of Italy [
[1]
,
[2]
]. However, data regarding the prevalence of cardiovascular (CV) comorbidities and
their potential impact on the short-term outcome of these patients have never been
investigated. Generally, preexisting chronic conditions such as CV (CVD), metabolic
and respiratory diseases are often associated with a greater risk of progression to
a worst outcome. Aim of the present study is to assess the prevalence of CV comorbidities
and their potential effect on the short-term survival in patients with confirmed WNV
infection.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Novel West Nile virus lineage 1a full genome sequences from human cases of infection in North-Eastern Italy, 2011.Clin Microbiol Infect. 2012; 18: E541-E544
- 2009 West Nile disease epidemic in Italy: first evidence of overwintering in Western Europe?.Res Vet Sci. 2011; 91: 321-326
- ESC scientific document group. 2018 ESC/ESH guidelines for the management of arterial hypertension.Eur Heart J. 2018; 39: 3021-3104
- Prevalence of chronic comorbidities in dengue fever and West Nile virus: a systematic review and meta-analysis.PLoS One. 2018; 13e0200200
- Long-term sequelae of West Nile virus-related illness: a systematic review.Lancet Infect Dis. 2015; 15: 951-959
- West Nile virus.Lancet Infect Dis. 2002; 2: 519-529
- Immune dysfunction in patients with diabetes mellitus (DM).FEMS Immunol Med Microbiol. 1999; 26: 259-265
Article info
Publication history
Published online: March 20, 2019
Accepted:
March 16,
2019
Received in revised form:
March 14,
2019
Received:
February 20,
2019
Identification
Copyright
© 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.